Publication
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Journal Paper/Review - Jun 1, 2018
Wirsching H-G, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm Ludwig, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger Thomas, Weller M
Wirsching, H-G
Tabatabai, G
Roelcke, U
Hottinger, A F
Jörger, F
Schmid, A
Plasswilm, Ludwig
chief physicianDepartment of Radiation Oncology · Dept. IV
Schrimpf, D
Mancao, C
Capper, D
Conen, K
Hundsberger, Thomas
chief of serviceNeurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I